Tesamorelin vs Epithalon
A comprehensive, data-driven comparison of Tesamorelin (Egrifta) and Epithalon (Epitalon). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | Tesamorelin Egrifta, TH9507 | Epithalon Epitalon, Epithalone |
|---|---|---|
| FDA Status | FDA Approved | Not submitted |
| Category | Growth Hormone | Anti-Aging |
| Primary Use | HIV-associated lipodystrophy | Anti-aging and longevity research |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $200 - $1,500/mo | $40 - $80/mo |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Typical Dose | 2mg daily | 5-10mg per cycle (10-20 days, 2-3x per year) |
| Frequency | Daily | Cyclical |
| Mechanism | Synthetic GHRH analog that reduces visceral adipose tissue by stimulating growth hormone production | Tetrapeptide that may activate telomerase enzyme to lengthen telomeres and potentially extend cellular lifespan |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | High | Emerging |
| Clinical Trial Phase | Approved | N/A |
Key Differences
- 1Tesamorelin is FDA-approved, while Epithalon is currently not submitted.
- 2Epithalon is generally more affordable ($40 - $80/mo) compared to Tesamorelin ($200 - $1,500/mo).
- 3Tesamorelin is dosed daily, while Epithalon is cyclical.
- 4Tesamorelin has high-quality evidence, while Epithalon has emerging-quality evidence.
- 5They belong to different categories: Tesamorelin (Growth Hormone) vs Epithalon (Anti-Aging).
Which Is Better For...
Tesamorelin
Those seeking an FDA-approved treatment with established safety data
Epithalon
More budget-friendly option with lower monthly costs
Epithalon
More convenient dosing schedule (cyclical)
Epithalon
Fewer commonly reported side effects
Tesamorelin
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| Tesamorelin | $200 - $1,500/mo | FDA Approved | Theratechnologies |
| Epithalon | $40 - $80/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
Tesamorelin works via Synthetic GHRH analog that reduces visceral adipose tissue by stimulating growth hormone. Epithalon works via Tetrapeptide that may activate telomerase enzyme to lengthen telomeres and potentially extend. They differ in FDA approval status, efficacy data, and cost.
Tesamorelin typically costs $200 - $1,500/mo, while Epithalon costs $40 - $80/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
Tesamorelin is FDA-approved. Epithalon is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of Tesamorelin include Injection site reactions, Arthralgia, Peripheral edema. Common side effects of Epithalon include Injection site reactions, Mild drowsiness, Vivid dreams. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
Tesamorelin is an FDA-approved synthetic growth hormone releasing hormone analog specifically indicated for reducing excess abdominal fat in HIV-infected patients with lipodystrophy. A new weekly reco...
View Full Tesamorelin GuideEpithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) researched primarily in Russia for its potential anti-aging properties. The proposed mechanism involves activation of telomerase, an enzyme that...
View Full Epithalon GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between Tesamorelin and Epithalon should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.